Pain News and Research

Latest Pain News and Research

Federal officials extend Ariz. Medicaid program while reviewing new plan; Wis. announces eligibility changes to cut budget shortfall

In other state Medicaid news, doctors in Washington state are suing to stop a new rule that limits enrollees' visits to the emergency department and Gov. Cuomo's administration dismisses a proposal for N.Y. to pay for transgender surgery.

4 Oct 2011

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Sangamo BioSciences, Inc. today announced that its Phase 2b study (SB-509-901) did not meet its primary or secondary clinical endpoints in subjects with moderate severity diabetic neuropathy (DN) as compared to placebo.

3 Oct 2011

Anesthesia and liposuction

Liposuction is a body contouring procedure, not a cure for obesity. The results are judged with a mirror and not a scale. The procedure is ideally suited for men and women with localized fat deposits that are resistant to diet and exercise. Men typically want their "spare tire" and excess fat on their chest removed, while women want their abdomen, hips, and thighs reduced.

3 Oct 2011

Alkermes initiates ALKS 37 phase 2b study in opioid-induced constipation

Alkermes plc today announced the initiation of a phase 2b study of ALKS 37, an orally active, peripherally restricted opioid antagonist for the treatment of opioid-induced constipation.

3 Oct 2011

Vexim obtains registration certificate for SpineJack in India

Vexim, the Med-Tech specialist in the minimally invasive, anatomical treatment of vertebral compression fractures, today announced that it has obtained the registration certificate for SpineJack in India.

3 Oct 2011

Improper footwear may lead to severe foot pain, impairment and disability in gout patients

New research shows that use of poor footwear is common among patients with gout. According to the study published in Arthritis Care & Research, a peer-reviewed journal of the American College of Rheumatology (ACR), gout patients who make poor footwear choices experienced higher foot-related pain, impairment and disability. Gout patients also reported that comfort, fit, support and cost were the most important factors for selecting footwear.

3 Oct 2011

FDA releases new PSA on safe medication use

The U.S. Food and Drug Administration (FDA) Office of Women's Health today released a new public service announcement (PSA) titled, "Use Medicines Wisely," to help raise awareness about safe medication use.

3 Oct 2011

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

David, a 67-year-old father of three and soon to be first-time grandfather, felt too young to be diagnosed with prostate cancer. "I felt great," he said. "I had no symptoms." David, under the advisement of his oncologist, decided to be treated with PROVENGE (sipuleucel-T), the first in a new therapeutic class known as autologous cellular immunotherapies.

1 Oct 2011

Vejthani Hospital brings Digital Lightbox to help surgeon plan the surgery pre-operatively

Vejthani Hospital Bangkok brought intelligent medical equipment in Orthopedic Knee Surgery, the so called "Digital lightbox", this can be used to enhance the capability of the Image Guided surgery (Computer Assisted Navigation System) for total joint replacement surgery.

1 Oct 2011

CSRO survey explores impact of health insurance barriers

The Coalition of State Rheumatology Organizations today released the findings of a nationwide survey that explored the impact of health insurance barriers such as prior authorization and step therapy on the ability of rheumatologists to provide effective care to patients.

1 Oct 2011

Survey calls for greater clinical consensus on diagnosis, treatment of breakthrough cancer pain

Today, the results from a European Survey of Oncology Nurse Breakthrough Cancer Pain Practices were presented for the first time at The European Multidisciplinary Cancer Congress in Stockholm.

1 Oct 2011

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Pfizer Inc. today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of invasive aspergillosis, a life-threatening invasive fungal infection that can develop as a complication in patients with compromised immune systems.

1 Oct 2011

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

An updated clinical practice guideline released last week by the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors recommends how to reduce the likelihood of blood clots after hip or knee replacement surgery, procedures that more than 800,000 Americans undergo each year. The new guideline suggests use of preventive treatments and advises against routinely screening patients after surgery using ultrasound imaging.

1 Oct 2011

Research roundup: What older patients really prize; DOD and the ACA

DOD Health Care: Cost Impact Of Health Care Reform And The Extension Of Dependent Coverage -- This study, mandated by Congress, assesses the financial impact of the federal health law on the Defense Department's budget.

1 Oct 2011

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Vertex Pharmaceuticals Incorporated today announced that abstracts from its hepatitis C program, including two late-breaking posters from studies of INCIVEK (telaprevir) tablets and VX-222, were accepted for presentation at The Liver Meeting, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, November 4-8, 2011.

1 Oct 2011

Lifespan researcher receives Ig Nobel Prize at Harvard University

Peter J. Snyder, Ph.D., vice president of research for Lifespan, received one of 10 Ig Nobel Prize awards during the annual ceremony last night at Harvard University.

1 Oct 2011

Takeda acquires Nycomed

Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day. Dr. Frank Morich has been named CEO of Nycomed in addition to his current role as Executive Vice President (EVP), International Operations, Takeda Pharmaceuticals International, Inc., a wholly owned subsidiary of Takeda America Holdings, Inc.

30 Sep 2011

Researchers use fMRI to examine patterns of brain activation in patients with chronic pain

Cognition is known to influence pain perception. As a result, several mind-body and psychological therapies are commonly used to treat chronic pain. A new study from the October issue of Anesthesiology analyzed whether two of the most commonly applied strategies involve different brain systems.

30 Sep 2011

FDA, other regulatory and international partners complete International Internet Week of Action

The U.S. Food and Drug Administration and other regulatory and international partners have completed the International Internet Week of Action (IIWA), a cooperative effort to curb online sales and distribution of counterfeit and illegal medical products.

30 Sep 2011

Four teams receive commercialization grant awards for development of new health-care products

Four Washington-based teams of investigators will receive up to $150,000 each to support commercial development of new health and health-care products, the Life Sciences Discovery Fund announced today.

30 Sep 2011

Pain News and Research

Latest Pain News and Research

Federal officials extend Ariz. Medicaid program while reviewing new plan; Wis. announces eligibility changes to cut budget shortfall

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Anesthesia and liposuction

Alkermes initiates ALKS 37 phase 2b study in opioid-induced constipation

Vexim obtains registration certificate for SpineJack in India

Improper footwear may lead to severe foot pain, impairment and disability in gout patients

FDA releases new PSA on safe medication use

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

Vejthani Hospital brings Digital Lightbox to help surgeon plan the surgery pre-operatively

CSRO survey explores impact of health insurance barriers

Survey calls for greater clinical consensus on diagnosis, treatment of breakthrough cancer pain

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

Research roundup: What older patients really prize; DOD and the ACA

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Lifespan researcher receives Ig Nobel Prize at Harvard University

Takeda acquires Nycomed

Researchers use fMRI to examine patterns of brain activation in patients with chronic pain

FDA, other regulatory and international partners complete International Internet Week of Action

Four teams receive commercialization grant awards for development of new health-care products

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in